Wei Liang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Chemotherapy Induced

Cognitive Impairment

Cell Proliferation

Top Venues

JMIR research protocols

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Sunyan Zhao, Jing Zhang, Haijun Wan, Chenjie Tao, Meng Hu, Wei Liang, Zhi Xu, Bingguo Xu, Jiaying Zhang, Guoxin Wang, Ping Li, Guangmei Lyu, Yongling Gong
Role of Chinese Acupuncture in the Treatment for Chemotherapy-Induced Cognitive Impairment in Older Patients With Cancer: Protocol for a Randomized Controlled Trial. JMIR research protocols 13 (2024)
Sunyan Zhao, Jing Zhang, Haijun Wan, Chenjie Tao, Meng Hu, Wei Liang, Zhi Xu, Bingguo Xu, Jiaying Zhang, Guoxin Wang, Ping Li, Guangmei Lyu, Yongling Gong
Role of Chinese Acupuncture in the Treatment for Chemotherapy-Induced Cognitive Impairment in Older Patients With Cancer: Protocol for a Randomized Controlled Trial. JMIR research protocols 13 (2024)
Sunyan Zhao, Jing Zhang, Haijun Wan, Chenjie Tao, Meng Hu, Wei Liang, Zhi Xu, Bingguo Xu, Jiaying Zhang, Guoxin Wang, Ping Li, Guangmei Lyu, Yongling Gong
Role of Chinese Acupuncture in the Treatment for Chemotherapy-Induced Cognitive Impairment in Older Patients With Cancer: Protocol for a Randomized Controlled Trial. JMIR research protocols 13 (2024)
Sunyan Zhao, Jing Zhang, Haijun Wan, Chenjie Tao, Meng Hu, Wei Liang, Zhi Xu, Bingguo Xu, Jiaying Zhang, Guoxin Wang, Ping Li, Guangmei Lyu, Yongling Gong
Role of Chinese Acupuncture in the Treatment for Chemotherapy-Induced Cognitive Impairment in Older Patients With Cancer: Protocol for a Randomized Controlled Trial. JMIR research protocols 13 (2024)
Wei Liang, Junfeng Shi, Haiyan Xia, Xiaowei Wei
A Novel Ruthenium-Fluvastatin Complex Downregulates SNCG Expression to Modulate Breast Carcinoma Cell Proliferation and Apoptosis via Activating the PI3K/Akt/mTOR/VEGF/MMP9 Pathway. Oxidative medicine and cellular longevity 2021 (2021)